Active, not recruitingNCT05768425

DIagnostic Biomarkers and Symptoms in Patients With Alzheimer's Disease and Lewy bodY Dementia

Studying NON RARE IN EUROPE: Alzheimer disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Danish Dementia Research Centre
Principal Investigator
Oskar McWilliam
Danish Dementia Research Centre, Rigshospitalet, Capital Region
Intervention
Real-time quaking-induced conversion (RT-QuIC)(diagnostic_test)
Enrollment
55 target
Eligibility
18 years · All sexes
Timeline
2023 – 2032

Study locations (1)

Collaborators

Danish Reference Center for Prion Diseases, Rigshospitalet · Department of Otorhinolaryngology, Head and Neck Surgery & Audiology, Rigshospitalet

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05768425 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Alzheimer disease →

← Back to all trials